| Physiotherapy for Improving Mental Health in Children and Adolescents With ASD and ADHD (NCT07231354) | International Hellenic University | 2022-06-28 |
| PDC-1421 Treatment in Adult Patients With ADHD (NCT05202327) | BioLite, Inc. | 2022-04-07 |
| Neuro-Nutrition to Support Physiological Function and Cognitive Skills in People With Down Syndrome, Autism Spectrum Disorder, and ADHD (NCT07165509) | Elizabeth Guadalupe Ibarra Coronado | 2022-03-26 |
| A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England (NCT05137704) | Takeda | 2021-12-01 |
| Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD (NCT04786990) | Supernus Pharmaceuticals, Inc. | 2021-07-27 |
| Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study (NCT04634006) | Onze Lieve Vrouw Hospital | 2020-11-05 |
| A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT02699086) | BioLite, Inc. | 2019-12-01 |
| Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD (NCT04016779) | Supernus Pharmaceuticals, Inc. | 2019-11-20 |
| Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12 (NCT06854601) | Pharmasoft | 2019-07-13 |
| Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD (NCT03638466) | Supernus Pharmaceuticals, Inc. | 2019-05-30 |
| Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity (NCT03481959) | Assistance Publique - Hôpitaux de Paris | 2019-05-07 |
| Drug Use Study With Intuniv® in Australia (NCT04866030) | Shire | 2019-03-11 |
| Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder (NCT04065906) | Xijing Hospital | 2019-01-15 |
| Drug Use Study With Intuniv® in European Countries (NCT05870605) | Shire | 2018-11-15 |
| A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. (NCT03580005) | Pfizer | 2018-10-31 |
| Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD. (NCT03546400) | Pfizer | 2018-09-25 |
| Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT03327402) | Shire | 2018-03-13 |
| Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) (NCT03325894) | Shire | 2018-01-02 |
| Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years (NCT03325881) | Shire | 2017-12-09 |
| Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) (NCT03260205) | Shire | 2017-09-06 |
| Probiotic Supplement as Treatment for Students With ADHD (NCT02908802) | Tel Hai College | 2016-11-01 |
| LearningRx Cognitive Training for ADHD (NCT02917109) | Gibson Institute of Cognitive Research | 2016-09-01 |
| A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD (NCT02884544) | Ironshore Pharmaceuticals and Development, Inc | 2016-08-01 |
| Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction (NCT02795637) | Sumitomo Pharma America, Inc. | 2016-05-01 |
| A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. (NCT02734693) | Sumitomo Pharma America, Inc. | 2016-04-30 |
| Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4) (NCT02691182) | Supernus Pharmaceuticals, Inc. | 2016-04-01 |
| The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) (NCT02788851) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2016-04-01 |
| Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) (NCT02618434) | Supernus Pharmaceuticals, Inc. | 2016-02-16 |
| Effects of Structured Skills Training Group in Treatment of ADHD in Adults (NCT02685254) | University of Oslo | 2016-02-01 |
| Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1) (NCT02618408) | Supernus Pharmaceuticals, Inc. | 2016-01-25 |
| Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD) (NCT02560454) | Assistance Publique - Hôpitaux de Paris | 2016-01-01 |
| Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too) (NCT02675400) | Seattle Children's Hospital | 2015-12-01 |
| Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) (NCT02604407) | Shire | 2015-11-19 |
| Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) (NCT02574273) | Weill Medical College of Cornell University | 2015-10-01 |
| Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder (NCT02466386) | Shire | 2015-08-21 |
| Brain Activity in Adults With ADHD During Neuropsychological Tasks (NCT02578342) | Kantonsspital Aarau | 2015-08-01 |
| Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT02466425) | Shire | 2015-06-18 |
| The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD (NCT02477748) | Alcobra Ltd. | 2015-06-01 |
| Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder (NCT02402166) | Shire | 2015-04-15 |
| The Correlation Between Blood omega3 and ADHD (NCT02391428) | Ayelet Omer Armon | 2015-04-01 |
| Trigeminal Nerve Stimulation for ADHD (NCT02155608) | University of California, Los Angeles | 2015-04-01 |
| Organizational Skill Training (OST) in Schools (NCT02663986) | NYU Langone Health | 2015-02-01 |
| 12 Month Open Extension of TNS for ADHD. (NCT03888391) | James McGough | 2014-12-01 |
| Four-week Open-trial Extension TNS for ADHD (NCT03870737) | University of California, Los Angeles | 2014-12-01 |
| Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) (NCT02257216) | Enzymotec | 2014-10-01 |
| Experimental Medicine in ADHD - Cannabinoids (NCT02249299) | King's College London | 2014-08-01 |
| PRC-063 in an ADULT Workplace Environment (NCT02225639) | Rhodes Pharmaceuticals, L.P. | 2014-08-01 |
| Assessing QbTest Utility in ADHD: A Randomised Controlled Trial (NCT02209116) | University of Nottingham | 2014-07-01 |
| Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD) (NCT02407496) | Think Now Incorporated | 2014-06-01 |
| Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting (NCT01986062) | Arbor Pharmaceuticals, Inc. | 2013-12-01 |
| NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) (NCT01835548) | Neos Therapeutics, Inc | 2013-07-01 |
| Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD) (NCT03709940) | King's College London | 2013-05-03 |
| Attention Intervention Management (NCT01779427) | Children's Hospital Medical Center, Cincinnati | 2013-01-01 |
| Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) (NCT02142140) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2012-12-01 |
| The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment) (NCT01750307) | King's College London | 2012-09-01 |
| Social Skills Group Training ("KONTAKT") for Children and Adolescent With High-functioning Autism Spectrum Disorders (NCT01854346) | Karolinska Institutet | 2012-08-01 |
| Self-help in Adjunct to Pharmacotherapy (NCT02174952) | University of Nottingham | 2012-07-01 |
| Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study (NCT01533493) | Massachusetts General Hospital | 2012-05-01 |
| Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe (NCT01500694) | Shire | 2012-03-20 |
| Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD) (NCT01542528) | Yale University | 2012-03-01 |
| Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits (NCT01399827) | Massachusetts General Hospital | 2012-02-01 |
| Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder (NCT01547702) | Dalhousie University | 2012-02-01 |
| Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (NCT01470261) | NHS Tayside | 2012-02-01 |
| Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder (NCT01430767) | Wake Forest University Health Sciences | 2011-09-01 |
| Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT01328756) | Shire | 2011-07-07 |
| Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder (NCT02074176) | National Taiwan University Hospital | 2011-01-01 |
| Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD) (NCT01363544) | R. van Mourik | 2010-06-01 |
| Evaluation of Immediate-Release Viloxazine in Adults With ADHD (NCT01107496) | Supernus Pharmaceuticals, Inc. | 2010-06-01 |
| Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate (NCT00931398) | University of Pittsburgh | 2010-04-01 |
| A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants (NCT01933880) | Xian-Janssen Pharmaceutical Ltd. | 2009-12-01 |
| Effect of Vyvanse on Driving in Young Adults With ADHD (NCT00801229) | Massachusetts General Hospital | 2008-12-01 |
| A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00323700) | University of British Columbia | 2008-12-01 |
| Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00735371) | Shire | 2008-10-08 |
| Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. (NCT00776009) | Novartis Pharmaceuticals | 2008-10-01 |
| Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults (NCT00753012) | Massachusetts General Hospital | 2008-04-01 |
| Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD (NCT00307268) | University of British Columbia | 2008-03-01 |
| Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD (NCT00631280) | Children's Hospital Medical Center, Cincinnati | 2007-09-01 |
| Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD (NCT00711724) | Massachusetts General Hospital | 2007-07-01 |
| A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) (NCT00475735) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD (NCT00500071) | Shire | 2007-06-28 |
| The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder (NCT00418184) | Enzymotec | 2007-03-01 |
| Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents (NCT00252278) | Rhode Island Hospital | 2005-11-01 |
| Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD (NCT00418262) | University of Oklahoma | 2005-08-01 |
| Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults (NCT01270555) | Massachusetts General Hospital | 1999-05-01 |
| Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. (NCT00399698) | Ohio State University | 1999-05-01 |